Fleur Pellerin

Board Member, Synapse Medicine
Greater Paris Metropolitan Region,France
Find Fleur Pellerin's Email
Find Fleur Pellerin's Phone

Who Is Fleur Pellerin?

Total Experience61 years
CompanySynapse Medicine
CountryFrance

Fleur Pellerin is a prominent French businesswoman and former politician. Born in Seoul, South Korea, and adopted by French parents, she pursued an elite education in France, graduating from ESSEC Business School, Sciences Po, and the École Nationale d'Administration (ENA). Her early career was in the French civil service as an auditor at the Court of Auditors. She later entered politics, serving in several ministerial roles under President François Hollande, including Minister for Small and Medium-sized Enterprises, Innovation, and the Digital Economy (2012-2014), Secretary of State for Foreign Trade, the Promotion of Tourism, and French Nationals Abroad (briefly in 2014), and Minister of Culture and Communication (2014-2016). In 2016, she resigned from government and founded Korelya Capital, a venture capital fund aimed at investing in European tech companies and fostering partnerships between Europe and Asia, particularly South Korea. She is recognized for her strong advocacy for innovation, digital transformation, and cultural development.

Fleur Pellerin LinkedIn pageCompany Website

How Did Fleur Pellerin's Career Path Shape Their Journey?

Fleur Pellerin's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Synapse Medicine - Board Member(2022 to Present)
FINN - Board Member(2022 to Present)
Crédit Mutuel Alliance Fédérale - Chairperson of the Mission Committee(2022 to Present)
Korelya Capital - CEO(2016 to Present)
KLM - Member of the Board(2018 to Present)
Talan - Member of the advisory committee(2016 to Present)
Devialet - Member of the Board(2017 to Present)
Ledger - Member of the Board(2018 to Present)
CANNESERIES - President(2017 to Present)
Schneider Electric - Member of the Board(2018 to 2022)

What Are Fleur Pellerin's Key Achievements?

Ministerial Leadership in French Government

Served in key ministerial positions, including Minister for SMEs, Innovation, and the Digital Economy (2012-2014) and Minister of Culture and Communication (2014-2016), significantly influencing French policy in these sectors.

Founder and CEO of Korelya Capital

Established Korelya Capital in 2016, a venture capital firm dedicated to backing promising European technology startups and helping them scale globally, with a particular focus on bridging European and Asian tech ecosystems.

Champion of 'La French Tech' Initiative

Played a pivotal role during her ministerial tenure in promoting and developing the 'La French Tech' initiative, significantly boosting the visibility and growth of the French startup scene.

Promotion of Digital Economy and Innovation

As Minister for the Digital Economy, she actively worked on policies to foster digital innovation, support startups, and enhance France's digital infrastructure and competitiveness.

What's Fleur Pellerin's Educational Background?

Promotion Averroès

National School of Administration (ENA) - Year 1998

Section Service Public

Institut d'Etudes politiques de Paris (Sciences-Po) - Year 1994

Degree Program

ESSEC - ESSEC Business School - Year 1991

French baccalaureate, German Abitur, Science section

Franco-German high school of Buc - Year 1990

Doctor of Arts

숙명여자대학교

Buying Intent Signals for Fleur Pellerin

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Synapse Medicine
Total employees135
HeadquartersBordeaux
Founded2017

Synapse Medicine is a medication intelligence platform dedicated to providing healthcare professionals and patients with reliable, up-to-date drug information to ensure proper medication use and prevent adverse drug events. Their AI-powered solutions assist in prescription decision-making, managing polypharmacy, and delivering clear medication guidance, ultimately aiming to improve patient safety and treatment efficacy.

Company Website
Synapse Medicine Funding Information
Unknown - Total Funding Raised
$28M - Most recent funding amount
3 - Number of funding rounds
16 Sep, 2021 - Latest funding round
Lead Investors:
Korelya Capital
XAnge
MACSF
BNP Paribas Development
Nicolas Garaud (Co-founder & CEO, Mindsay - acquired by Laiye)
Anne-Sophie Pastel (Operating Partner, XAnge)
Alexandre Fretti (Managing Director, Webhelp)

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Intent Signals

Buyer intent signals

CRM Enrichment

Contact Enrichment

Workflows and tasks

Workflows and tasks

Integrations

Integrations

Thousands of companies, including, are just a search away.